Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
November 19, 2025
Not intended for U.S. and UK Media
Lynkuet™ (elinzanetant) approved in the EU for the treatment of moderate to severe vasomotor symptoms associated with menopause or endocrine therapy for breast cancer
November 12, 2025
Business figures for the third quarter:
Bayer confirms 2025 Group outlook, progresses on strategic priorities
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
